or
Remember me
Back
Webinar Recap: Antibe Therapeutics $ATE w CEO Dan Legault - Pitch, Deep Dive and Q&A - https://youtu.be/5_M2ucaYGoQ
CEO Dan Legault provides a corporate update, including the progress of ATE's lead drug otenaproxesul, targeting acute pain, as well as updates on ATB-352 and its inflammatory bowel disease (IBD) program.
A daily snapshot of everything from market open to close.